Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

2022 Journal of the National Comprehensive Cancer Network 1,326 citations

Abstract

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non–Small Cell Lung Cancer (NSCLC) provide recommended management for patients with NSCLC, including diagnosis, primary treatment, surveillance for relapse, and subsequent treatment. Patients with metastatic lung cancer who are eligible for targeted therapies or immunotherapies are now surviving longer. This selection from the NCCN Guidelines for NSCLC focuses on targeted therapies for patients with metastatic NSCLC and actionable mutations.

Keywords

MedicineOncologyInternal medicineLung cancerClinical PracticeClinical OncologyCancerTargeted therapyIntensive care medicineFamily medicine

Affiliated Institutions

Related Publications

Publication Info

Year
2022
Type
article
Volume
20
Issue
5
Pages
497-530
Citations
1326
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

1326
OpenAlex

Cite This

David S. Ettinger, Douglas E. Wood, Dara L. Aisner et al. (2022). Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network , 20 (5) , 497-530. https://doi.org/10.6004/jnccn.2022.0025

Identifiers

DOI
10.6004/jnccn.2022.0025